| 发明名称 |
C. PERFRINGENS ALPHA TOXOID VACCINE |
| 摘要 |
The present invention describes vaccines that comprise C. perfringens Type alpha toxoids, antigenic fragments thereof, inactivated antigenic fragments of C. perfringens Type alpha toxins, or any combination thereof. The present invention further describes methods of using with these vaccines to protect animals against clostridial diseases. The present invention also describes methods of making these vaccines. |
| 申请公布号 |
US2015140033(A1) |
申请公布日期 |
2015.05.21 |
| 申请号 |
US201514608577 |
申请日期 |
2015.01.29 |
| 申请人 |
Intervet Inc. |
发明人 |
Jayappa Huchappa;O'Connell Kevin |
| 分类号 |
A61K39/08;A61K39/108 |
主分类号 |
A61K39/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A vaccine against Clostridium perfringens (C. perfringens) comprising a C. perfringens Type A alpha toxoid supernatant that was concentrated by ultrafiltration and has 2 or more TCP;
wherein the C. perfringens alpha toxoid supernatant comprises an alpha toxoid antigen; with the proviso that only a single C. perfringens Type alpha toxoid antigen is present in said vaccine; and wherein said vaccine is both safe and immunologically effective against a clostridial disease. |
| 地址 |
Summit NJ US |
